✦ LIBER ✦

A Short-Term, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study

✍ Scribed by JEAN-YVES LE HEUZEY; GAETANO M. DE FERRARI; DAVID RADZIK; MASSIMO SANTINI; JUNREN ZHU; JEAN-MARC DAVY

Book ID: 109208463
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 308 KB
Volume: 21
Category: Article
ISSN: 1540-8167
DOI: 10.1111/j.1540-8167.2010.01764.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

✍ Oliver Distler; Wolfgang Eich; Eva Dokoupilova; Zdenek Dvorak; Martin Fleck; Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

A double-blind, randomized, parallel gro

A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification

✍ Ekkehard Madlung-Kratzer; Berhard Spitzer; Renate Brosch; Dirk Dunkel; Christian 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

AFFECT: a prospective, open-label, multi

AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation

✍ Ulrich Tebbe; Ralph Oeckinghaus; Karl-Friedrich Appel; Hubertus Heuer; Hendrik H 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 267 KB

A randomized, double-blind study compari

A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis

✍ Koo; FOR THE OLP302 STUDY GROUP 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients with severe, chronic plaque-type psoriasis. Patients were randomized on a 1:1 basis to 24 weeks of treatment with Neoral (n = 152) or Sandimmun (n = 157). The starting dose

Efficacy, tolerability, and safety of ra

Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: A randomized double-blind clinical trial

✍ Eugene Ramsay; Edward Faught; Allan Krumholz; Dean Naritoku; Michael Privitera; 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 208 KB